Raven Lin
CEO,
Pilatus Biosciences
Switzerland
Raven Lin, an accomplished leader in the biotech sector, co-founded Pilatus Biosciences following his tenure as Vice President of corporate development at I-Mab (Nasdaq: IMAB). With pivotal roles at Mycenax Biotech Inc. (4726.TWO) and SynCore Biotechnology Co. Ltd. (4192.TWO), he’s a driving force in business development, orchestrating over 3 billion in licensing transactions. Known for his agile leadership, he excels at steering cross-functional teams through challenging business terrains.
Suffix
PhD
Sessions
-
10-Feb-2025